Elizabeth L. Ross

ORCID: 0000-0001-9473-343X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Radiopharmaceutical Chemistry and Applications
  • Immune Response and Inflammation
  • Cancer Cells and Metastasis
  • Suicide and Self-Harm Studies
  • CAR-T cell therapy research
  • Glycosylation and Glycoproteins Research
  • Personality Disorders and Psychopathology
  • T-cell and B-cell Immunology
  • Urticaria and Related Conditions
  • Substance Abuse Treatment and Outcomes
  • Mast cells and histamine
  • Cancer Research and Treatments
  • Contact Dermatitis and Allergies
  • Cannabis and Cannabinoid Research
  • Cutaneous lymphoproliferative disorders research
  • Childhood Cancer Survivors' Quality of Life
  • HIV-related health complications and treatments
  • Angiogenesis and VEGF in Cancer
  • Preterm Birth and Chorioamnionitis
  • Cardiovascular Conditions and Treatments
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Immunotoxicology and immune responses

Province of Antwerp
2024

HistoGeneX (Belgium)
2018

Michael E. DeBakey VA Medical Center
2012-2013

Health Services Research & Development
2013

University of Houston
2012-2013

Baylor College of Medicine
2012

St Bartholomew's Hospital
1999-2001

John Radcliffe Hospital
2001

The Honourable Society of Lincoln's Inn
2001

Guy's Hospital
1994-1995

Journal Article Tumour necrosis factor alpha is pro‐inflammatory in normal human skin and modulates cutaneous adhesion molecule expression Get access R. W. GROVES, GROVES Dunhill Dermatology Laboratory. St John's Institute, of Dermatology, UMDS, Guy's Hospital, London SEI 9RT, U.K. R.W.Groves, Division Dermatology. Brigham Women's Hospital. 75, Francis Street, Boston, MA 02115. U.S.A. Search for other works by this author on: Oxford Academic Google Scholar M. H. ALLEN, ALLEN E. L. ROSS, ROSS...

10.1111/j.1365-2133.1995.tb08666.x article EN British Journal of Dermatology 1995-03-01

Journal Article Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria Get access R.J. BARLOW, BARLOW St John's Institute of Dermatology. Thomas' Hospital, Lambeth Palace Road, London SE1 7EH. U.K. Search for other works by this author on: Oxford Academic Google Scholar E.L. ROSS, ROSS Guy's London, D. MACDONALD, MACDONALD A.KOBZA BLACK, BLACK M.W. GREAVES British Dermatology, Volume 131, Issue 3, 1 September 1994, Pages 341–347,...

10.1111/j.1365-2133.1994.tb08521.x article EN British Journal of Dermatology 1994-09-01

To examine the role of baseline depression, anxiety and stress symptoms on post-intervention diabetes self-efficacy glycaemic control (HbA(1c)).The current study analysed data from patients (n = 85) with treated but uncontrolled Type 2 who participated in a comparative effectiveness two self-management interventions. Hierarchical linear regression was used to relationships between affective moderating effects relationship changes HbA(1c).Baseline depression inversely associated (P 0.0001)...

10.1111/dme.12146 article EN Diabetic Medicine 2013-01-28

Summary Mast cells are considered to be the primary effector in urticaria but it is possible that lymphocytes contribute formation of weals by secreting histamine releasing factors. The aim this study was examine population mast and quantify T cell subsets their activation status delayed pressure (DPU), chronic idiopathic normal controls. Three biopsies were obtained from each four patients with not DPU. taken 13 DPU, a combination unchallenged skin at 0, 2, 6, 24, 48 120 h after weighted...

10.1111/j.1365-2222.1995.tb01049.x article EN Clinical & Experimental Allergy 1995-04-01

ABSTRACT Suicide ideation and attempts are a major health concern among adolescents, recently, evidence has emerged suggesting that borderline personality disorder (BPD) may put individuals at even greater risk than depression alone. This is not surprising given within adult samples, 8–10% of those diagnosed with BPD commit suicide. However, only handful studies have assessed the relation between suicide currently, nothing known about characteristics adolescents BPD. Against this background,...

10.1002/pmh.1202 article EN Personality and Mental Health 2012-06-14

Current cocaine treatments may be enhanced with a better understanding of the underlying mechanisms that contribute to onset and maintenance disease, such as life stress impulsivity. Life impulsivity have previously been studied independently contributors drug use, current study expands upon past research by examining how these factors interact one another. The aim was evaluate role in predicting non-treatment seeking cocaine-dependent sample (N=112). Analyses revealed trait (as measured...

10.1016/j.pnpbp.2013.06.002 article EN cc-by Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013-06-21

We evaluated the efficacy and safety of ketorolac (Toradol).In this prospective trial, 88 women in confirmed preterm labor at < or =32 weeks' gestation were randomized to receive magnesium sulfate given as an initial 6 g intravenous bolus followed by continuous infusion therapy (2 g/hr) intramuscularly administered (60 mg loading dose) 30 every hours for a maximum 24 hours.The study groups similar with respect age, parity, cervical status, gestational age on admission. Ketorolac was more...

10.1097/00007611-199811000-00007 article EN Southern Medical Journal 1998-11-01

Monoclonal antibodies (mAbs) have been used to treat malignancies in humans with varying degrees of success. Progress has hindered by the lack suitable animal models, which would ideally consist immunocompetent animals that are tolerant tumor-associated antigens. Suitable models allow study and optimization anti-tumor immunotherapy. We describe a murine model for immunotherapy colorectal cancers. Carcinoembryonic antigen (CEA) is cell-surface glycoprotein expressed on normal human intestinal...

10.1073/pnas.181353498 article EN Proceedings of the National Academy of Sciences 2001-08-21

MUC1 is a membrane bound, polymorphic epithelial mucin expressed at the luminal surface of glandular epithelium. It highly in an underglycosylated form on carcinomas and metastatic lesions is, therefore, potential target for immunotherapy cancer. The monoclonal antibody HMFG1 binds linear core protein sequence, PDTR, contained within immunodominant domain tandem repeat MUC1. efficacy murine humanized (Ab1) used as anti-idiotypic vaccine was examined mice transgenic human (MUC1.Tg) challenged...

10.1054/bjoc.2000.1431 article EN cc-by-nc-sa British Journal of Cancer 2000-11-01
Coming Soon ...